CybeRelease: (OTC: MNCL) Has a Shareholder Update

(CybeRelease, February 2, 2007) - Mr. Harvey Panesar, President of Martin Nutraceuticals Inc. (PINKSHEETS:MNCL - News) reports that “from a corporate perspective, 2006 was a very full and exciting year for Martin Nutraceuticals Inc. In 2006, Martin Nutraceuticals was able to complete several of its key corporate objectives, which included retail exposure, a television campaign to support retail activities in Eastern Canada, completion of Dr. Martin’s new book and a Direct Response Television (DRTV) campaign.”

In 2006, Martin Nutraceuticals Inc. (MNI) obtained numerous listings with several key retailers for its flagship products. These listings enabled MNI to build brand exposure and a retail presence while the company completed a television campaign geared for Quebec operations.

Steady sales for MNI’s flagship products continue as the company shifted focus in the second half of 2006 to concentrate on the launch of Dr. Martin’s new book, Medical Crisis - Secrets Your Doctor Won’t Share With You. The company made a corporate decision to change its marketing strategies by focusing on completing a Direct Response Television (DRTV) campaign to launch the Medical Crisis book in North America. Management strongly feels that the successful airing of the DRTV for the Medical Crisis book will result in increased retail demand of the company’s flagship products going into the U.S. market. “We believe that the success of the book will be a great introduction to the fantastic products of Martin Nutraceuticals,” states Mr. Panesar. “If the public is reading the book, it will give them a far better insight into how our products will contribute to their overall health.”

“The DRTV industry is a multi-billion dollar industry and we immediately added more credibility to what we are aiming to achieve by choosing a reputable firm like Opfer Communications to implement our DRTV campaign,” continued Mr. Panesar. The company is hoping to run the test market for the DRTV campaign early in the second quarter of 2007. This will provide ratings and customer feedback for the company before the nationwide launch of the DRTV campaign in Q3 of 2007.

One other key area, which the company has been focusing on, is the back-end solutions for the DRTV campaign. The company is very close to completing negotiations with call-center service providers and fulfillment centers, which are an integral part of any DRTV, campaign.

Martin Nutraceuticals has been in the process of re-branding the online image of the company. “We realize that our online growth could possibly be a lucrative avenue and one that we are preparing to fully explore,” states Mr. Panesar. “The online community does millions of dollars of purchases monthly and we fully intend to tap into this market.”

To read the complete release, go to http://biz.yahoo.com/bw/070202/20070202005424.html?.v=1.

For a Free Newsletter, go to http://www.OTCReporter.com.

CybeRelease Gainers are AMIS Holdings, Inc. (Nasdaq: AMIS), Digimarc Corporation (Nasdaq: DMRC), Conn’s, Inc. (Nasdaq: CONN), Hudson Highland Group, Inc. (Nasdaq: HHGP), ev3 Inc. (Nasdaq: EVVV), Intuitive Surgical, Inc. (Nasdaq: ISRG), Syntax-Brillian Corporation (Nasdaq: BRLC) and American Technology Corporation (Nasdaq: ATCO).

CybeRelease Decliners are Ventana Medical Systems, Inc. (Nasdaq: VMSI), AtheroGenics, Inc. (Nasdaq: AGIX), webMethods, Inc. (Nasdaq: WEBM), Sonic Solutions (Nasdaq: SNIC), Tumbleweed Communications Corp. (Nasdaq: TMWD), infoUSA, Inc. (Nasdaq: IUSA), Computer Programs and Systems, Inc. (Nasdaq: CPSI) and Cohu, Inc. (Nasdaq: COHU).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact:
C. P. Barry
Company: CybeRelease
Phone: 1.888.478.7669
Source: CybeRelease.com

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail